The research frontier: what we're studying next.
An honest map of the open questions, from recovery to mitochondrial function.
We'd rather show you the map than sell you the destination. Here's an honest account of what the science behind phytovive has established, and what it hasn't, yet.
What's proven
The core of it rests on human data. In a randomized, double-blind, placebo-controlled trial, the strain up-regulated the NRF2 (↑1.62×) and SIRT1 (↑1.73×) master switches and several of the body's own antioxidant-enzyme genes. That human result sits on two decades of laboratory and cellular work on the strain's antioxidant activity. This is the substantiated ground we stand on.
What we're studying
Because NRF2 and SIRT1 sit upstream of so much, the open questions are wide. Published and ongoing work is exploring the strain's role in recovery and aerobic capacity, in mitochondrial function, and in cellular longevity, including how cells protect their telomeres under oxidative stress. These are directions of active study. They are not claims, and we won't dress them up as ones.
What comes next
We're investing in our own research, designed to deepen exactly these questions rather than restate what's already known. As it reports, you'll read it here, the results that flatter us and the ones that complicate the story alike.
Honesty is a strange thing to make a selling point of. In a field this young, we think it's the only one worth having.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.